A Evaluation Of Biomarkers Associated With Sports Induced Concussions In College Student Athletes (GATOR)
A Prospective Evaluation Of Biomarkers Associated With Sports Induced Concussions In College Student Athletes
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32610
- University of Florida
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- The subject is a University of Florida student athlete on a team participating in the study
- The Subject is at least 18 years of age at screening (has had their 18th birthday)
- The Subject is willing to undergo the Informed Consent process prior to enrollment into this study.
- It is the Principal Investigator's opinion that based on the knowledge of the Subject that the Subject is an appropriate candidate for the study.
Exclusion Criteria:
- Participating in another clinical study that may affect the results of either study.
- Venipuncture not feasible (i.e. skin integrity compromised at the venipuncture sites, blood vessel calcification.
- Not available for the end of season follow-up visit.
- The Subject is otherwise determined by the Investigator to be medically unsuitable for participation in this study.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Sports induced concussion
Exposure to sports induced concussion
|
Biomarkers to detect specific proteins.
|
|
Routine Athletic Exertion
Exposure to routine athletic exertion (non-concussion control)
|
Biomarkers to detect specific proteins.
|
|
Other Non-Penetrating Trauma to the Head
Exposure to other non-penetrating trauma to the head that is witnessed or self-reported
|
Biomarkers to detect specific proteins.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in levels of TBI biomarkers from baseline
Time Frame: 36 months
|
36 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Association of TBI biomarker levels and the Post-Concussion Scale
Time Frame: 36 months
|
36 months
|
|
|
Association of TBI biomarker levels and the Standardized Assessment of Concussion
Time Frame: Baseline (beginning of Sports season), Active Phase (during Sports Season) and End of Sports Season
|
Baseline (beginning of Sports season), Active Phase (during Sports Season) and End of Sports Season
|
|
|
Association of TBI biomarker levels and the Balance Error Scoring System
Time Frame: 36 months
|
36 months
|
|
|
Safety
Time Frame: Throughout Participation in Study
|
The safety endpoints include the cumulative procedure-related adverse event-free survival, and cumulative unanticipated procedure-related adverse events.
The only potential risks to patients in this study are those that are normally related to routine blood collection.
|
Throughout Participation in Study
|
|
Assessment of pituitary status and determination of the presence of autoantibodies.
Time Frame: 36 months
|
36 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Jay Clugston, MD, University of Florida
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- ATO-07
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.